Skip to main content
Top
Published in: Critical Care 1/2004

01-02-2004 | Poster presentation

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial

Authors: D Thabut, R de Franchis, F Bendtsen, G D'Amico, A Albillos, JG Abraldes, S Sofelt, J Bosch, the European Study Group on rFVIIa in UGI hemorrhage

Published in: Critical Care | Special Issue 1/2004

Login to get access

Excerpt

Upper gastrointestinal bleeding (UGIB) is a severe and frequent complication of cirrhosis. Preliminary results show that rFVIIa may reduce bleeding in cirrhotic patients. This trial aimed to determine the efficacy and safety of rFVIIa in cirrhotic patients with variceal and nonvariceal UGIB. …
Metadata
Title
Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
Authors
D Thabut
R de Franchis
F Bendtsen
G D'Amico
A Albillos
JG Abraldes
S Sofelt
J Bosch
the European Study Group on rFVIIa in UGI hemorrhage
Publication date
01-02-2004
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2603

Other articles of this Special Issue 1/2004

Critical Care 1/2004 Go to the issue